Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor

Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor

US Patent 5958413 · Granted Sep 28, 1999

Estimated economic value: $2,009,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating immune disorders using immune modulating L2022
Interleukin-5 specific recombinant antibodies2007
Interleukin-5 specific recombinant antibodies2004
Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xa2002
Pharmaceutical product for the treatment of sepsis2001
Nucleic acids encoding interleukin-5 specific recombinant antibodies2001
Use of theophylline derivatives for the treatment and prophylaxis of states of s2001
Use of theophylline derivatives for the treatment and prophylaxis of states of s2001
Humanized antibodies2001
Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xa2000
Use of estrone derivatives as steroid sulphatase inhibitors2000
Interleukin-5 specific recombinant antibodies1999